There were 1,754 press releases posted in the last 24 hours and 442,541 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image